218 related articles for article (PubMed ID: 29110648)
1. Prospective study of
Yomo S; Oguchi K
BMC Cancer; 2017 Nov; 17(1):713. PubMed ID: 29110648
[TBL] [Abstract][Full Text] [Related]
2. Comparison of (11)C-methionine, (11)C-choline, and (18)F-fluorodeoxyglucose-PET for distinguishing glioma recurrence from radiation necrosis.
Takenaka S; Asano Y; Shinoda J; Nomura Y; Yonezawa S; Miwa K; Yano H; Iwama T
Neurol Med Chir (Tokyo); 2014; 54(4):280-9. PubMed ID: 24305028
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy of 11C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy.
Terakawa Y; Tsuyuguchi N; Iwai Y; Yamanaka K; Higashiyama S; Takami T; Ohata K
J Nucl Med; 2008 May; 49(5):694-9. PubMed ID: 18413375
[TBL] [Abstract][Full Text] [Related]
4. Methionine positron emission tomography of recurrent metastatic brain tumor and radiation necrosis after stereotactic radiosurgery: is a differential diagnosis possible?
Tsuyuguchi N; Sunada I; Iwai Y; Yamanaka K; Tanaka K; Takami T; Otsuka Y; Sakamoto S; Ohata K; Goto T; Hara M
J Neurosurg; 2003 May; 98(5):1056-64. PubMed ID: 12744366
[TBL] [Abstract][Full Text] [Related]
5. Methionine positron emission tomography for differentiation of recurrent brain tumor and radiation necrosis after stereotactic radiosurgery--in malignant glioma.
Tsuyuguchi N; Takami T; Sunada I; Iwai Y; Yamanaka K; Tanaka K; Nishikawa M; Ohata K; Torii K; Morino M; Nishio A; Hara M
Ann Nucl Med; 2004 Jun; 18(4):291-6. PubMed ID: 15359921
[TBL] [Abstract][Full Text] [Related]
6. Semiquantitative analysis of C-11 methionine PET may distinguish brain tumor recurrence from radiation necrosis even in small lesions.
Okamoto S; Shiga T; Hattori N; Kubo N; Takei T; Katoh N; Sawamura Y; Nishijima K; Kuge Y; Tamaki N
Ann Nucl Med; 2011 Apr; 25(3):213-20. PubMed ID: 21188660
[TBL] [Abstract][Full Text] [Related]
7. Determination of brain tumor recurrence using
Yamaguchi S; Hirata K; Okamoto M; Shimosegawa E; Hatazawa J; Hirayama R; Kagawa N; Kishima H; Oriuchi N; Fujii M; Kobayashi K; Kobayashi H; Terasaka S; Nishijima KI; Kuge Y; Ito YM; Nishihara H; Tamaki N; Shiga T
Cancer Sci; 2021 Oct; 112(10):4246-4256. PubMed ID: 34061417
[TBL] [Abstract][Full Text] [Related]
8. Role of O-(2-(18)F-fluoroethyl)-L-tyrosine PET for differentiation of local recurrent brain metastasis from radiation necrosis.
Galldiks N; Stoffels G; Filss CP; Piroth MD; Sabel M; Ruge MI; Herzog H; Shah NJ; Fink GR; Coenen HH; Langen KJ
J Nucl Med; 2012 Sep; 53(9):1367-74. PubMed ID: 22872742
[TBL] [Abstract][Full Text] [Related]
9. Differentiation of Brain Tumor Recurrence from Post-Radiotherapy Necrosis with 11C-Methionine PET: Visual Assessment versus Quantitative Assessment.
Minamimoto R; Saginoya T; Kondo C; Tomura N; Ito K; Matsuo Y; Matsunaga S; Shuto T; Akabane A; Miyata Y; Sakai S; Kubota K
PLoS One; 2015; 10(7):e0132515. PubMed ID: 26167681
[TBL] [Abstract][Full Text] [Related]
10. Differentiation between Treatment-Induced Necrosis and Recurrent Tumors in Patients with Metastatic Brain Tumors: Comparison among
Tomura N; Kokubun M; Saginoya T; Mizuno Y; Kikuchi Y
AJNR Am J Neuroradiol; 2017 Aug; 38(8):1520-1527. PubMed ID: 28619837
[TBL] [Abstract][Full Text] [Related]
11.
Govaerts CW; van Dijken BR; Stormezand GN; van der Weide HL; Wagemakers M; Enting RH; van der Hoorn A
Br J Radiol; 2021 Sep; 94(1125):20210275. PubMed ID: 34233489
[TBL] [Abstract][Full Text] [Related]
12. Utility of Dynamic Susceptibility Contrast Perfusion-Weighted MR Imaging and
Qiao Z; Zhao X; Wang K; Zhang Y; Fan D; Yu T; Shen H; Chen Q; Ai L
AJNR Am J Neuroradiol; 2019 Feb; 40(2):253-259. PubMed ID: 30655259
[TBL] [Abstract][Full Text] [Related]
13. Accuracy of F-DOPA PET and perfusion-MRI for differentiating radionecrotic from progressive brain metastases after radiosurgery.
Cicone F; Minniti G; Romano A; Papa A; Scaringi C; Tavanti F; Bozzao A; Maurizi Enrici R; Scopinaro F
Eur J Nucl Med Mol Imaging; 2015 Jan; 42(1):103-11. PubMed ID: 25182751
[TBL] [Abstract][Full Text] [Related]
14. Differential diagnosis between radiation necrosis and glioma progression using sequential proton magnetic resonance spectroscopy and methionine positron emission tomography.
Nakajima T; Kumabe T; Kanamori M; Saito R; Tashiro M; Watanabe M; Tominaga T
Neurol Med Chir (Tokyo); 2009 Sep; 49(9):394-401. PubMed ID: 19779283
[TBL] [Abstract][Full Text] [Related]
15. Comparison of C-11 methionine and C-11 choline for PET imaging of brain metastases: a prospective pilot study.
Rottenburger C; Hentschel M; Kelly T; Trippel M; Brink I; Reithmeier T; Meyer PT; Nikkhah G
Clin Nucl Med; 2011 Aug; 36(8):639-42. PubMed ID: 21716012
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic accuracy of
Kits A; Martin H; Sanchez-Crespo A; Delgado AF
Ann Nucl Med; 2018 Feb; 32(2):132-141. PubMed ID: 29280066
[TBL] [Abstract][Full Text] [Related]
17. Clinical impact of (11)C-methionine PET on expected management of patients with brain neoplasm.
Yamane T; Sakamoto S; Senda M
Eur J Nucl Med Mol Imaging; 2010 Apr; 37(4):685-90. PubMed ID: 19915838
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous evaluation of brain metastasis and thoracic cancer using semiconductor
Kaneko K; Nagao M; Ueda K; Yamamoto A; Sakai S
Ann Nucl Med; 2024 Apr; 38(4):278-287. PubMed ID: 38386272
[TBL] [Abstract][Full Text] [Related]
19. The value of
Garcia JR; Cozar M; Baquero M; Fernández Barrionuevo JM; Jaramillo A; Rubio J; Maida G; Soler M; Riera E
Rev Esp Med Nucl Imagen Mol; 2017; 36(2):85-90. PubMed ID: 27503425
[TBL] [Abstract][Full Text] [Related]
20. Clinical usefulness of 11C-MET PET and 201T1 SPECT for differentiation of recurrent glioma from radiation necrosis.
Sonoda Y; Kumabe T; Takahashi T; Shirane R; Yoshimoto T
Neurol Med Chir (Tokyo); 1998 Jun; 38(6):342-7; discussion 347-8. PubMed ID: 9689817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]